Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Momenta Appoints Biosimilars Unit President | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Momenta Appoints Biosimilars Unit President

Franken to oversee operational management of biosimilars program

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Michael Franken, M.D. has been appointed president of Momenta Pharmaceuticals’ Biosimilars Business and will serve as a member of the executive committee. Dr. Franken will oversee the operational management of the company’s biosimilars program, including its collaboration with Baxter International Inc., strategic planning, P&L responsibility, and other supporting activities. Dr. Franken will report to Craig Wheeler, Momenta’s president and chief executive officer.
 
Dr. Franken previously served as senior vice president and chief business officer of Radius Health, where he was responsible for the company’s commercial, business development, and strategy functions for its Phase III bone anabolic medicine to treat osteoporosis. Prior to Radius, he served as vice president and general manager, Solid Organ Transplantation, at Genzyme. During his 10-year career at Genzyme, he also held senior positions in corporate development portfolio and general management.
 
“Momenta’s biosimilars business presents an attractive opportunity for growth,” said Mr. Wheeler. “Michael brings more than 17 years of broad experience to the company, including a valuable combination of operations skills, market expertise and business development. With this focus, we will better align our resources and expertise to create an even stronger collaboration with Baxter to advance this core business.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics